Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Share News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes
Get Live Data
46.00    1.40 (3.04%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £94.57m
FARN Live PriceLast checked at - London Stock Exchange

Intraday Faron Pharmaceuticals Share Chart

Faron Pharmaceuticals News

Faron Pharmaceuticals Raises EUR1.3 Million Via Share Subscription (ALLISS)
14 May 2019

Faron Pharmaceuticals Raises EUR1.3 Million Via Share Subscription (ALLISS)

LONDON (Alliance News) - Biopharmaceutical company Faron Pharmaceuticals Ltd said Tuesday that it has raised EUR1.3 million via share subscription.The...

Faron Pharmaceuticals Narrows Loss On Reduced Clinical Trial Costs
7 May 2019

Faron Pharmaceuticals Narrows Loss On Reduced Clinical Trial Costs

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Tuesday reported a slightly narrowed annual loss as the drug developer's research & development ...

Faron Pharmaceuticals Knows Of No Reason For 43% Share Price Jump
2 May 2019

Faron Pharmaceuticals Knows Of No Reason For 43% Share Price Jump

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it is unable to explain the recent movement in its share price.Faron noted Thursda...

UK Earnings, Trading Statements Calendar - Next 7 Days
30 Apr 2019

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 1 May J SainsburyFull Year ResultsConnect GroupHalf Year GroupQ1 Stock

Faron Gets Results Of Traumakine Study From Japanese Licensing Partner
29 Apr 2019

Faron Gets Results Of Traumakine Study From Japanese Licensing Partner

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said its Japanese licensing partner Maruishi Pharmaceutical Co Ltd has provided clinical t...

Faron Pharmaceuticals To Focus On Colorectal Cancer In Clevegen Trial
11 Apr 2019

Faron Pharmaceuticals To Focus On Colorectal Cancer In Clevegen Trial

LONDON (Alliance News) - Faron Pharmaceuticals Oy is to target colorectal cancer in its upcoming test programme for Clevegen, it said Thursday.The tes...

Faron Pharmaceuticals upbeat on latest info from MATINS trial
11 Apr 2019

Faron Pharmaceuticals upbeat on latest info from MATINS trial

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Thursday that the cohort expansion part of its phase 1 ...

UPDATE: Faron Pharmaceuticals Raises EUR3.1 Million In Fundraise (ALLISS)
26 Mar 2019

UPDATE: Faron Pharmaceuticals Raises EUR3.1 Million In Fundraise (ALLISS)

LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday afternoon said it has raised EUR3.1 million pursuant to a placing announced ear...